Search Results - "Di Perna, F"

6ER-017 In vitro evaluation of mouth-dissolving tablets containing repaglinide-B-cyclodextrin complex by Coppolino, S, Di Perna, F

“…BackgroundRepaglinide is an oral hypoglycemic drug especially useful for the treatment of type 2 diabetes. This molecule has poor aqueous solubility, which is…”
Get full text

3PC-001 Determination of metoclopramide hydrochloride release from tablets containing mixtures of cellulose polymers by Coppolino, S, Perna, F Di

“…BackgroundMetoclopramide hydrochloride (MCC) is an antiemetic drug rapidly absorbed from the gastrointestinal tract, with a half-life reduced and…”
Get full text

PP-015 Release of acyclovir from liposomes: An in vitro study by Coppolino, S, Federico, F, Di Perna, F

“…BackgroundLiposomes are small spherical artificial vesicles that can be created from cholesterol and natural non-toxic phospholipids and are used as carriers…”
Get full text

Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD by Cazzola, M., Matera, M.G., Di Perna, F., Califano, C., D'Amato, M., Mazzarella, G.

“…We examined the influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in patients with partially reversible…”
Get full text

Comparative Study of Dirithromycin and Azithromycin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis by Cazzola, M., Vinciguerra, A., Perna, F. Di, Califano, C., Calderaro, F., Salzillo, A., Centanni, S.

“…We compared the clinical and microbiological efficacy of dirithromycin with that of azithromycin in outpatients with acute bacterial exacerbations of chronic…”
Get full text

Interrelationship Between the Pharmacokinetics and Pharmacodynamics of Cefaclor Advanced Formulation in Patients with Acute Exacerbations of Chronic Bronchitis by Cazzola, M., Perna, F. Di, Boveri, B., Marco, F. Di, Diamare, F., Centanni, S.

“…Cefaclor advanced formulation (cefaclor AF) is an extended-release form of the oral cephalosporin cefaclor. When cefaclor AF 750 mg twice-daily and cefaclor…”
Get full text

Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease by Cazzola, M., D'Amato, M., Califano, C., Di Perna, F., Calderaro, F., Matera, M.G., D'Amato, G.

“…Background: Acute exacerbations of chronic obstructive pulmonary disease (COPD) are managed with increased doses or frequency of the patient's existing…”
Get full text

Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD by Cazzola, M, Di Perna, F, Noschese, P, Vinciguerra, A, Calderaro, F, Girbino, G, Matera, MG

“…We examined whether a pretreatment with formoterol, oxitropium bromide, or salmeterol might modify the dose-response curves to inhaled salbutamol in patients…”
Get full text

Role of negative transthoracic echocardiography in excluding infective endocarditis by Cambise, N, Tremamunno, S, Marino, A, Lenci, L, De Benedetto, F, Belmusto, A, Tinti, L, Di Renzo, A, Di Perna, F, Buonamassa, G, Pontecorvo, S, Lombardo, A, Lanza, G A

“…Abstract Background Recent guidelines suggest an extensive role of transesophageal echocardiography (TOE) in the diagnostic work-up for suspected infective…”
Get full text

A Five-Day Course of Dirithromycin in the Treatment of Acute Exacerbation of Severe Chronic Obstructive Pulmonary Disease by Cazzola, M., Caputi, M., Santangelo, G., Vinciguerra, A., Perna, F. Di, Polverino, M.

“…Since dirithromycin persists at high concentrations in the lung for at least 3 days following the last dose of a 5-day course, we evaluated the clinical…”
Get full text

A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease by Cazzola, M., Matera, M.G., Di Perna, F., Calderaro, F., Califano, C., Vinciguerra, A.

“…Anti-cholinergic agents are generally regarded as the bronchodilator therapy of first choice in the treatment of stable chronic obstructive pulmonary disease…”
Get full text

Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease by Cazzola, Mario, Di Perna, Felice, Centanni, Stefano, Califano, Clara, Donner, Claudio Ferdinando, D'Amato, Maria, D'Amato, Gennaro

“…BACKGROUND An earlier study documented that, in patients with chronic obstructive pulmonary disease (COPD), addition of ipratropium bromide at the clinically…”
Get full text

Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease by Cazzola, M., Vinciguerra, A., Di Perna, F., Matera, M.G.

“…The assessment of reversibility is recognized as being an essential part of the management of airways obstruction, but testing for reversibility of airways…”
Get full text

Incremental Benefit of Adding Oxitropium Bromide to Formoterol in Patients with Stable COPD by Cazzola, M., Di Perna, F., Califano, C., Vinciguerra, A., D»Amato, M.

“…The effects of the long-acting β2-agonist formoterol, the anticholinergic drug oxitropium bromide, and their combination were compared in 16 patients with…”
Get full text

Formoterol Turbuhaler®for as-needed therapy in patients with mild acute exacerbations of COPD by CAZZOLA, M., DI PERNA, F., D'AMATO, M., CALIFANO, C., MATERA, M.G., D'AMATO, G.

“…Worsening of underlying bronchospasm may be associated with acute exacerbations of chronic obstructive pulmonary disease (COPD). As airway obstruction becomes…”
Get full text

Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD by CAZZOLA, M, CALIFANO, C, DI PERNA, F, D'AMATO, M, TERZANO, C, MATERA, M.G, D'AMATO, G, MARSICO, S.A

“…Worsening of underlying bronchospasm may be associated with acute exacerbations of chronic obstructive pulmonary disease (COPD). As airway obstruction becomes…”
Get full text

Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia by Cazzola, M, Imperatore, F, Salzillo, A, Di Perna, F, Calderaro, F, Imperatore, A, Matera, M G

“…There are several reports of documented adverse cardiac effects during treatment with beta-agonists. Since one should be aware that this may be a problem in…”
Get more information

Additive effects of salmeterol and fluticasone or theophylline in COPD by Cazzola, M, Di Lorenzo, G, Di Perna, F, Calderaro, F, Testi, R, Centanni, S

“…ss(2)-Agonists and corticosteroids or theophylline can interact to produce beneficial effects on airway function in asthma, but this has not been established…”
Get more information

A comparison of the bronchodilating effects of salmeterol, salbutamol and Ipratropium bromide in patients with chronic obstructive pulmonary disease by Matera, M.G., Cazzola, M., Vinciguerra, A., Di Perna, F., Calderaro, F., Caputi, M., Rossi, F.

“…Bronchodilator efficacy of salbutamol (200 μg), salmeterol (50 μg) and ipratropium bromide (40 μg) aerosols las been compared in 16 patients with stable…”
Get full text

Onset of Action of Single Doses of Formoterol Administered via Turbuhaler in Patients with Stable COPD by Cazzola, Mario, Centanni, Stefano, Regorda, Claudia, di Marco, Fabiano, di Perna, Felice, Carlucci, Paolo, Boveri, Barbara, Santus, Pierachille

“…We studied 16 patients with stable COPD in a double blind, double dummy, placebo-controlled, within patient study to see if formoterol could be used as a…”
Get full text